Medicare Enrolled

Dr. Simona Bartos, DO

MOHS-Micrographic Surgery Physician · Hollywood, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4700 SHERIDAN ST STE I, Hollywood, FL 33021
9549372294
In practice since 2006 (19 years)
NPI: 1174553846 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bartos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bartos? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bartos

Dr. Simona Bartos is a mohs-micrographic surgery physician in Hollywood, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bartos performed 2,505 Medicare services across 790 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bartos received a total of $9,871 from 37 pharmaceutical and/or device companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bartos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 2,505 Medicare services $9,871 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 14856 Clear March 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
2,505
Medicare services
Bottom 42% in FL for mohs-micrographic surgery physician
790
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~132 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,228 $5 $19
Novachor implant, per square centimeter
This code represents the supply of Novachor, a biologic implant material, measured by each square centimeter used during a procedure.
235 $808 $1,033
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
209 $29 $198
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
188 $85 $333
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
118 $97 $381
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
115 $47 $297
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
100 $69 $269
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
88 $40 $149
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $118 $500
Skin growth removal and lab exam, 1-5 blocks
This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory.
33 $488 $1,951
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks 33 $325 $1,217
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $85 $336
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
20 $142 $532
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
19 $120 $500
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
13 $33 $169
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
11 $1 $3
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,871
Total received (2018-2024)
Avg $1,410/year across 7 years
Top 21% in FL for mohs-micrographic surgery physician
37
Companies
354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,871 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,366
2023
$1,642
2022
$311
2021
$608
2020
$744
2019
$2,241
2018
$1,960

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie Inc.
$1,261
Organogenesis Inc.
$1,134
AbbVie, Inc.
$996
Regeneron Healthcare Solutions, Inc.
$794
Novartis Pharmaceuticals Corporation
$716
GENZYME CORPORATION
$639
ABBVIE INC.
$579
PFIZER INC.
$495
Janssen Biotech, Inc.
$390
Lilly USA, LLC
$314
Galderma Laboratories, L.P.
$249
Janssen Scientific Affairs, LLC
$238
Genentech USA, Inc.
$230
SUN PHARMACEUTICAL INDUSTRIES INC.
$214
Mallinckrodt Hospital Products Inc.
$194
Celgene Corporation
$142
Helsinn Therapeutics (U.S.), Inc.
$139
Biofrontera Inc.
$126
Amgen Inc.
$120
UCB, Inc.
$111
Ortho Dermatologics, a division of Bausch Health US, LLC
$108
Allergan Inc.
$97
Incyte Corporation
$94
Sun Pharmaceutical Industries Inc.
$92
E.R. Squibb & Sons, L.L.C.
$61
LEO Pharma Inc.
$59
Verrica Pharmaceuticals Inc.
$53
MAYNE PHARMA COMMERCIAL LLC
$34
Dermavant Sciences, Inc.
$30
VYNE Pharmaceuticals Inc.
$27
NOVARTIS PHARMACEUTICALS CORPORATION
$24
MAYNE PHARMA INC.
$22
Smith+Nephew, Inc.
$22
Kyowa Kirin, Inc.
$18
Journey Medical Corporation
$18
SANOFI-AVENTIS U.S. LLC
$18
Arcutis Biotherapeutics, Inc.
$16
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ADBRY · AMELUZ · AMZEEQ · BOTOX · Bimzelx · CIBINQO · COLLAGENASE SANTYL · COSENTYX · CYGNUS DUAL · Cimzia · DERMATITIS - DISEASE · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · HUMIRA · Humira · ILUMYA · LIBTAYO · MATRIX · NOVACHOR · OPZELURA · Otezla · POTELIGEO · Puraply · REMICADE · RINVOQ · SILIQ · SKYRIZI · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Winlevi · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $394 per 100 Medicare services performed
Looking for a mohs-micrographic surgery physician in Hollywood?
Compare mohs-micrographic surgery physicians in the Hollywood area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

Mohs-micrographic surgery physicians within 10 mi
28
Per 100K population
1.4
County median income
$74,534
Nearest hospital
MEMORIAL REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bartos is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bartos experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Bartos performed 1,228 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bartos receive payments from pharmaceutical companies?
Yes. Dr. Bartos received a total of $9,871 from 37 companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bartos's costs compare to other mohs-micrographic surgery physicians in Hollywood?
Dr. Bartos's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bartos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →